Healthcare

Friday witnessed a dramatic sell-off in Grail's stock, triggered by disappointing news from a major clinical study. While the core...

Shares of ResMed are consolidating near the $258 mark, taking a pause after a robust second fiscal quarter performance. The...

After a punishing start to the trading year, UnitedHealth shares are showing tentative signs of recovery. However, this recent upward...

The telehealth company Hims & Hers finds itself navigating a perfect storm of regulatory scrutiny and legal action, leading to...

Eli Lilly and Company is showcasing a multi-faceted growth strategy, with recent developments underscoring that its expansion is not solely...

ProPhase Labs is undergoing a significant portfolio review, with the potential sale of core business units now under consideration. The...

IMAC Holdings is undergoing a significant corporate transformation, fundamentally shifting its core business model. The company is moving away from...

The primary objective for 22nd Century Group remains clear: reaching profitability by 2026. The company is intensifying efforts to scale...

BridgeBio Pharma announced yesterday the successful completion of the pivotal Phase 3 PROPEL 3 study evaluating Infigratinib. The data demonstrate...

Intuitive Surgical finds itself at an interesting juncture, with recent insider transactions and a tempered growth outlook drawing investor scrutiny...